{Reference Type}: Journal Article
{Title}: Cellular adhesion molecules in drug-naïve and previously medicated patients with schizophrenia-spectrum disorders.
{Author}: Varden Gjerde K;Bartz-Johannessen C;Steen VM;Andreassen OA;Steen NE;Ueland T;Lekva T;Rettenbacher M;Joa I;Reitan SK;Johnsen E;Kroken RA;
{Journal}: Schizophr Res
{Volume}: 267
{Issue}: 0
{Year}: 2024 May 3
{Factor}: 4.662
{DOI}: 10.1016/j.schres.2024.03.029
{Abstract}: <B>BACKGROUND: </B>Endothelial inflammation may be involved in the pathogenesis of schizophrenia, and cellular adhesion molecules (CAMs) on endothelial cells may facilitate leukocyte binding and transendothelial migration of cells and inflammatory factors. The aim of the present study was to assess levels of soluble cellular adhesion molecules, including intercellular adhesion molecule (ICAM)-1, vascular adhesion molecule (VCAM)-1, mucosal addressin cell adhesion molecule (MADCAM), junctional adhesion molecule (JAM-A) and neural cadherin (N-CAD) in patients with schizophrenia compared to healthy controls.<BR><B>METHODS: </B>The study population consists of 138 patients with schizophrenia-spectrum disorder, of whom 54 were drug-naïve, compared to 317 general population controls. The potential confounders age, gender, smoking and body mass index (BMI) were adjusted for in linear regression models.<BR><B>RESULTS: </B>The total patient group showed significantly higher levels of ICAM-1 (p < 0.001) and VCAM-1 (p < 0.001) compared to controls. Previously medicated patients showed higher ICAM-1 levels compared to drug-naïve patients (p = 0.042) and controls (p < 0.001), and elevated VCAM-1 levels compared to controls (p < 0.001). Drug-naive patients had elevated levels of VCAM-1 (p = 0.031) compared to controls.<BR><B>CONCLUSIONS: </B>In our study, patients with schizophrenia - including the drug-naïve - have higher levels of soluble CAMs compared to healthy controls. These findings suggest activation of the endothelial system as in inflammation.